Search
Search
About
Log in
Join
Experiences with
Cabozantinib
Posts
Communities
24 public posts
Filter results
Genitourinary Cancers Symposium Meeting Coverage, MedPage Today, January 2024
meetingcoverage/mgucs/108464 [i]
Another Prostate Cancer Screening Candidate Outperforms Standard PSA Testing: Multiparametric Stockholm3 avoided far more unnecessary biopsies without sacrificing sensitivity, January 28, 2024:
[/i] https://www.medpagetoday.com/meetingcoverage/mgucs/108457 [i]
meetingcoverage/mgucs/108464 [i]
Another Prostate Cancer Screening Candidate Outperforms Standard PSA Testing: Multiparametric Stockholm3 avoided far more unnecessary biopsies without sacrificing sensitivity, January 28, 2024:
[/i] https://www.medpagetoday.com/meetingcoverage/mgucs/108457 [i]
cujoe
in
Fight Prostate Cancer
5 months ago
BLA for Subcutaneous Nivolumab Accepted by the FDA for Advanced/Metastatic Solid Tumors
hyaluronidase (rHuPH20; subcutaneous nivolumab) for adult patients with solid tumors eligible for previously approved nivolumab indications as monotherapy, monotherapy maintenance following completion of nivolumab plus ipilimumab (Yervoy) combination therapy, or in combination with chemotherapy or
cabozantinib
hyaluronidase (rHuPH20; subcutaneous nivolumab) for adult patients with solid tumors eligible for previously approved nivolumab indications as monotherapy, monotherapy maintenance following completion of nivolumab plus ipilimumab (Yervoy) combination therapy, or in combination with chemotherapy or
cabozantinib
God_Loves_Me
in
Advanced Prostate Cancer
28 days ago
CONTACT-02 Phase III: Cabozantinib-Atezolizumab combination works well in mCRPC with soft tissue metastasis
https://www.urotoday.com/video-lectures/asco-gu-2024/video/mediaitem/3890-contact-02-phase-iii-trial-findings-on-
cabozantinib
-atezolizumab-combination-in-mcrpc-neeraj-agarwal.html
https://www.urotoday.com/video-lectures/asco-gu-2024/video/mediaitem/3890-contact-02-phase-iii-trial-findings-on-
cabozantinib
-atezolizumab-combination-in-mcrpc-neeraj-agarwal.html
Maxone73
in
Advanced Prostate Cancer
4 months ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
COSMIC-021 trial
Cabozantinib
plus atezolizumab showed promising antitumour activity in patients with metastatic castration-resistant prostate cancer after novel hormonal therapy with an acceptable safety profile, supporting further evaluation of this combination. https://www.thelancet.com/journals/lanonc/article/PIIS1470
Cabozantinib
plus atezolizumab showed promising antitumour activity in patients with metastatic castration-resistant prostate cancer after novel hormonal therapy with an acceptable safety profile, supporting further evaluation of this combination. https://www.thelancet.com/journals/lanonc/article/PIIS1470
spw1
in
Advanced Prostate Cancer
2 years ago
Trial Involving Cabozantinib
Hi everyone, Dad has been informed he may be potentially eligible for a trial involving
cabozantinib
and atezolizumab. Has anybody had any dealings with this and if so, did it seem effective? Many thanks as always!
Hi everyone, Dad has been informed he may be potentially eligible for a trial involving
cabozantinib
and atezolizumab. Has anybody had any dealings with this and if so, did it seem effective? Many thanks as always!
Hillwalker87
in
Advanced Prostate Cancer
3 years ago
Immunotherapy Clinical Trial or Olaparib (Lynparza)?
We've been offered two options: 1. a trial of atezolizumab +
cabozantinib
- an immunotherapy treatment that seems to be promising in Breast Cancer. But, if he is put into the control group, he'd receive enzalutamide (another ADT drug). 2.
We've been offered two options: 1. a trial of atezolizumab +
cabozantinib
- an immunotherapy treatment that seems to be promising in Breast Cancer. But, if he is put into the control group, he'd receive enzalutamide (another ADT drug). 2.
PCdaughte
in
Advanced Prostate Cancer
3 years ago
Cabozantinib and Keytruda
Update on my dad, he continues on the above combo treatment. His PSA keeps decreasing and his liver tumors keep shrinking. Very hopeful, it’s now been a one year that his liver was invaded by the prostate cancer.
Update on my dad, he continues on the above combo treatment. His PSA keeps decreasing and his liver tumors keep shrinking. Very hopeful, it’s now been a one year that his liver was invaded by the prostate cancer.
JC531
in
Advanced Prostate Cancer
3 years ago
Not a candidate for the CAR-T trial. Should I pursue cabozantinib here in the USA or look abroad for LU-177?
The Mayo Clinic has accepted me to get either
cabozantinib
(XL184) alone or in combination with atezolizumab (immunotherapy).
Cabozantinib
is an oral agent which is great and is FDA approved for medullary thyroid cancer. This is a phase 2 study.
The Mayo Clinic has accepted me to get either
cabozantinib
(XL184) alone or in combination with atezolizumab (immunotherapy).
Cabozantinib
is an oral agent which is great and is FDA approved for medullary thyroid cancer. This is a phase 2 study.
Cleodman
in
Advanced Prostate Cancer
4 years ago
High PSA with Mets in Check
I’ve been on a clinical trial of a combo of
Cabozantinib
and Atezolizumab for three months now. It’s a combination of pill and infusion. My Mets that involve my lungs, liver and lymph nodes are staying in check. But my PSA climbs 20 spots every three weeks of my treatment.
I’ve been on a clinical trial of a combo of
Cabozantinib
and Atezolizumab for three months now. It’s a combination of pill and infusion. My Mets that involve my lungs, liver and lymph nodes are staying in check. But my PSA climbs 20 spots every three weeks of my treatment.
RalphieJr64
in
Advanced Prostate Cancer
4 years ago
Free vs Total Testosterone? - Redux.
A total of 34 patients with continuous measurements of FT levels and mCRPC status underwent therapy with docetaxel, abiraterone acetate, enzalutamide,
cabozantinib
, carboplatin or cabazitaxel.
A total of 34 patients with continuous measurements of FT levels and mCRPC status underwent therapy with docetaxel, abiraterone acetate, enzalutamide,
cabozantinib
, carboplatin or cabazitaxel.
pjoshea13
in
Advanced Prostate Cancer
4 years ago
HCC (hepato cellular carcinoma ) patient survey
Have you been diagnosed with HCC and are currently on oral systemic therapy drug treatment for liver cancer (for example, sorafenib, regorafenib, nivolumab, lenvatinib, pembrolizumab, or
cabozantinib
)? If so, we’d like to ask for your help.
Have you been diagnosed with HCC and are currently on oral systemic therapy drug treatment for liver cancer (for example, sorafenib, regorafenib, nivolumab, lenvatinib, pembrolizumab, or
cabozantinib
)? If so, we’d like to ask for your help.
Hidden
Partner
in
British Liver Trust
4 years ago
After two years, My trial has now stopped working
My MO wants to start chemo again or another clinical trial combo of
Cabozantinib
-Atezolizumab. I wish they would come up with easier names of these drugs. I have to be off my last trial for four weeks to start this new adventure. The side effects like my last trial are debilitating.
My MO wants to start chemo again or another clinical trial combo of
Cabozantinib
-Atezolizumab. I wish they would come up with easier names of these drugs. I have to be off my last trial for four weeks to start this new adventure. The side effects like my last trial are debilitating.
RalphieJr64
in
Advanced Prostate Cancer
4 years ago
Do you have liver cancer?
Urgent help needed We are looking for one or two patients who have liver cancer and are currently being treated by systemic drug therapy (e.g. regorafenib, nivolu¬mab, lenvatinib, pembrolizumab, and
cabozantinib
) to help us with the design of a patient survey.
Urgent help needed We are looking for one or two patients who have liver cancer and are currently being treated by systemic drug therapy (e.g. regorafenib, nivolu¬mab, lenvatinib, pembrolizumab, and
cabozantinib
) to help us with the design of a patient survey.
Hidden
British Liver Trust
in
British Liver Trust
4 years ago
Promising Clinical Activity of Cabozantinib + ADT in Hormone-Naïve Metastatic Prostate Cancer
We evaluated
cabozantinib
plus androgen deprivation therapy (ADT) in hormone-naïve metastatic prostate cancer (HNMPCa). PATIENTS AND METHODS Patients received ADT plus
cabozantinib
starting at 60 mg daily.
We evaluated
cabozantinib
plus androgen deprivation therapy (ADT) in hormone-naïve metastatic prostate cancer (HNMPCa). PATIENTS AND METHODS Patients received ADT plus
cabozantinib
starting at 60 mg daily.
Balsam01
in
Advanced Prostate Cancer
4 years ago
Cabozantinib shows promising results
https://www.practiceupdate.com/C/95606/56?elsca1=emc_enews_topic-alert
https://www.practiceupdate.com/C/95606/56?elsca1=emc_enews_topic-alert
TNCanuck
in
Advanced Prostate Cancer
4 years ago
New drug consultation
I would like to know if someone from the community experimented with
cabozantinib
, they told me that it is a practically new drug. If so, what side effects did they experience? Would they be similar to those of sunitinib or pazopanib? Thank you all!
I would like to know if someone from the community experimented with
cabozantinib
, they told me that it is a practically new drug. If so, what side effects did they experience? Would they be similar to those of sunitinib or pazopanib? Thank you all!
Mafaldaaa
in
Kidney Cancer Support
4 years ago
Stopping Braftovi Mektovi targeted medications
if accepted in the clinical trial screening or per expanded access, may take oral
cabozantinib
as part of a trial/ expanded access drug use (currently used for kidney cancer inhibitor for folks with a Met amplification genetic alteration; being studied now for melanoma with this genetic profile, which
if accepted in the clinical trial screening or per expanded access, may take oral
cabozantinib
as part of a trial/ expanded access drug use (currently used for kidney cancer inhibitor for folks with a Met amplification genetic alteration; being studied now for melanoma with this genetic profile, which
missyrand
Ambassador
in
Melanoma Caregivers
4 years ago
Chemo failed- Anyone with experience on Cabozantinib and Opdivo?
My father’s medical oncologist Based on his pathology reports and genetic mutations will decide if my father will go on with Keytruda or will qualify and get excepted to the trial use of Optiva and
Cabozantinib
.
My father’s medical oncologist Based on his pathology reports and genetic mutations will decide if my father will go on with Keytruda or will qualify and get excepted to the trial use of Optiva and
Cabozantinib
.
Daddysdaughter
in
Advanced Prostate Cancer
6 years ago
free Testosterone [fT] & survival.
"A total of 34 patients with continuous measurements of FT levels and mCRPC status underwent therapy with docetaxel, abiraterone acetate, enzalutamide,
cabozantinib
, carboplatin or cabazitaxel."
"A total of 34 patients with continuous measurements of FT levels and mCRPC status underwent therapy with docetaxel, abiraterone acetate, enzalutamide,
cabozantinib
, carboplatin or cabazitaxel."
pjoshea13
in
Advanced Prostate Cancer
7 years ago
Role of free testosterone levels in mCRPC.
A total of 34 patients with continuous measurements of FT levels and mCRPC status underwent therapy with docetaxel, abiraterone acetate, enzalutamide,
cabozantinib
, carboplatin or cabazitaxel.
A total of 34 patients with continuous measurements of FT levels and mCRPC status underwent therapy with docetaxel, abiraterone acetate, enzalutamide,
cabozantinib
, carboplatin or cabazitaxel.
pjoshea13
in
Advanced Prostate Cancer
7 years ago
1
2
Next page
Filter results
Clear filters
Posted in
All communities
Advanced Prostate Cancer
17 results
British Liver Trust
2 results
Fight Prostate Cancer
1 result
View top 10 communities
Sort by
Most Relevant
Newest